Elelyso
Chemical Name | taliglucerase alfa |
Dosage Form | Injection (intravenous; 200 units/vial) |
Drug Class | Enzymes |
System | Blood |
Company | Pfizer |
Approval Year | 2012 |
Indication
- For the treatment of type 1 Gaucher disease in patients 4 years and older with a confirmed diagnosis